News

10 October, 2024

CLS and ClearPoint Neuro at CNS 2024 in Houston

Last week we joined the 2024 Congress of Neurological Surgeons (CNS) meeting in Houston where our partner ClearPoint Neuro, Inc. exhibited the ClearPoint Prism® Neuro Laser Therapy System, powered by CLS. In addition to good booth traffic and customer discussions, we also took part in the scientific program providing the latest updates on the use of Laser Interstitial Thermal Therapy (LITT) in neurosurgery.

Read more
30 September, 2024

Two Abstracts on CLS TRANBERG system accepted for the 15th FTS Annual Meeting

Both abstracts provide the latest insights into the clinical use of focal laser ablation for prostate cancer, contributing to the ongoing development of minimally invasive cancer therapies.

Read more
4 September, 2024

CLS Training Camp in Turin, Italy

On the 29th of August, CLS organized a training camp for our European distributors within urology and their Clinical Applications Specialists. During two intense days in Turin, Italy, the team learned a lot about the treatment of localized prostate cancer using the CLS TRANBERG® product portfolio, both in theory and in practice.

Read more
25 June, 2024

CLS Newsletter, June 2024

Now, when summer is approaching and we're all looking forward to enjoying some days off, it's time to sumarize the news from the first half of 2024.

Read more
26 April, 2024

CLS at Imperial Prostate Masterclass in London

The Imperial Prostate Masterclass meeting in London brings together key opinion leaders in urology and experts in focal therapy from around the world. AS part of the program CLS hosted a hands-on training session.

Read more
31 January, 2024

CLS Newsletter, January 2024

For CLS it has been an intense start to the year with many positive news. Read about what has been happening with a focus on actions to future proof our core technology, an update on market expansion, andew company presentations.

Read more
20 December, 2023

CLS at Focal Therapy Masterclass meeting in Paris

For CLS this meeting offered a perfect opportunity to meet with both the leading experts, and with clinicians about to introducing focal therapy in their clinic.

Read more
17 November, 2023

Customer Experience AVANT Concierge Urology

Learn about our progress within the Mobile Service Provider Model enabling more clinics to treat prostate cancer patients.

Read more
7 November, 2023

Podcast Episode with Insight from the US Market

Listen to a podcast episode with Michael Magnani, President of CLS Americas and Dr Garrett D. Pohlman, urologist at Kearney and the host of the Prostate Health Podcast. They had an engaging discussion around the key features and benefits of using the TRANBERG system for the treatment of low to intermediate localized prostate cancer.

Read more
1 November, 2023

CLS Supports Movember

This month, men all around the world are growing mustaches to raise awareness for men's health issues, such as prostate cancer, testicular cancer, mental health, and suicide prevention. It's more than just a mustache; it's a movement to make a difference in the lives of men everywhere.

Read more
22 September, 2023

Newsletter September 2023 with Commercial & Medical Milestones

In this edition of our newsletter, you can read more about CLS’s commercial and medical milestone that was achieved at AVANT Concierge Urology in the US, and exhibitions where our TRANBERG® system and the ClearPoint Prism™ system, powered by CLS, have been demonstrated. We are also proud to present three new members that will strengthen the CLS team.

Read more
6 September, 2023

Interview with CLS's Executive VP Operations – Jimmy Johansson

With his long experience from the medical device and healthcare sectors, Jimmy Johansson has been a great asset to CLS since 2015. Among other things, Jimmy was the project manager behind the development of Thermoguide™ Workstation, our tool for monitoring and control of MRI-guided laser ablation. In May this year Jimmy was appointed CLS´s Executive VP Operations. This is a new coordinating management function created to streamline our operations and secure the company’s continued growth. We caught up with Jimmy to hear more. Joel has shared his journey with CLS. Let’s hear what he said.

Read more
29 August, 2023

NEW: Video showing how laser ablation is monitored using CLS Thermoguide™ Workstation

Watch our new video from a patient case to get an insight into how physicians can monitor a laser ablation procedure in near real time.

Read more
1 August, 2023

Interview with CLS's Director of Clinical Operations - Joel Hix

We are happy to introduce Joel Hix, Director of Clinical Operations at CLS Americas. Joel has over 15 years of senior management experience in operations, sales, marketing, and service with leading medical device manufacturers including Boston Scientific and Healthtronics.

Read more
28 June, 2023

Abstract from the SUS Study to be presented during the ESSFN Congress in Stockholm in September

For the first time results from the CLS-sponsored study at Skåne University Hospital (SUS) will be presented and discussed during an international scientific congress. We are happy to share the abstract OP033 “Laser interstitial thermal therapy using an uncooled laser catheter in a diagnostic MR suite” by Dr Hjalmar Bjartmarz et al.

Read more
5 May, 2023

CLS Americas and Unio Health Partners Announce Clinical Study

We are happy to share that CLS Americas has entered into an agreement with Genesis Research, LLC, an affiliate of Unio Health Partners, to conduct a Phase I clinical study titled, “Micro Ultra-Sound Guided, Transperineal Focal Laser Ablation of Low-to-Intermediate Risk Prostate Cancer.”

Read more
13 April, 2023

CLS Americas Announces Research Collaboration with the National Institutes of Health Clinical Center

Under the agreement, NIHCC will access the clinical utility of the CLS’s TRANBERG® Thermal Therapy System towards MRI/Ultrasound fusion-guided focal laser ablation (FLA) of prostate tissue and prostate cancer in male patients.

Read more
21 March, 2023

NEW: Animation showing Fusion-guided Focal Laser Ablation in Prostate Cancer

We are proud to release a detailed video animation of the minimally invasive, fusion-guided, focal laser ablation (FLA) of a prostate tumor using the TRANBERG™ Thermal Therapy System.

Read more
21 March, 2023

Post-Market Study to Evaluate CLS’s TRANBERG Thermal Therapy System by HALO Dx

We are happy to share that HALO Diagnostics, Inc. (HALO Dx) will evaluate the safety and short term efficacy of CLS’s TRANBERG® Thermal Therapy System for treating low-to-medium risk prostate cancer patients.

Read more
1 February, 2023

How it Works – Learn more about Laser Ablation in Neurosurgery

Since CLS´s laser ablation system for neurosurgery was cleared by the FDA in September last year development has progressed rapidly. But how does it actually work? We explain in this news post.

Read more
19 January, 2023

Press Release from Skåne University Hospital on the Ongoing Study using CLS Products for Neurosurgery inside the MRI Camera

Today Skåne University Hospital (SUS) published a press release with the title “Laser surgery in a magnetic camera – new help for patients with brain tumors”. The PM provides an insight to the ongoing study using CLS products for laser surgery inside a MRI camera. The hospital writes that doctors now can treat patients with hard-to-reach brain tumors that medical care was previously unable to help. So far two patients with brain tumors have been successfully treated as part of the study.

Read more
15 December, 2022

Interview with and research by Dr Eric Walser University of Texas Medical Branch

Dr Eric Walser is an internationally recognized interventional radiologist with extensive clinical experience of using non-surgical ablation for the treatment of small tumors as an alternative to traditional surgery. Dr Eric Walser uses the TRANBERG® Thermal Therapy System to treat localized prostate cancer in clinical practice.

Read more
12 December, 2022

CLS announces first glioblastoma patient treated with the MR-guided Laser Interstitial Thermal Therapy (MRg LITT) in the study at Skåne University Hospital

CLS today announced that the first patient has been safely treated in the clinical trial at Skåne University Hospital (SUS) aiming to evaluate MR-guided Laser Interstitial Thermal Therapy (MRg LITT) for glioblastoma ablation.

Read more
28 November, 2022

Clinical data from a Phase II trial using CLS TRANBERG products presented during RSNA 2022 Annual Meeting

The RSNA (Radiological Society of North America) annual meeting is ongoing in Chicago, the US. Yesterday, interim data from the ongoing study in Toronto using CLS´s TRANBERG products, was presented by the principal investigator MD Sangeet Ghai.   

Read more
24 November, 2022

Our CTO Cristina Pantaleone awarded Technician of the Year by the Chamber of Commerce

We are happy to announce that our Chief Technology Officer Cristina Pantaleone today has been awarded Technician of the Year by the Chamber of Commerce and Industry of Southern Sweden.

Read more
8 November, 2022

Scientific presentations related to the use of CLS TRANBERG® products at the 13th iMRI Symposium in Leipzig

We want to highlight a couple of scientific presentations held during the 13th Interventional MRI Symposium 2022 in Leipzig, October 14-15, 2022. This event provides an ideal platform for researchers, clinicians, and healthcare professionals alike to present their latest results within interventional MRI.

Read more
2 November, 2022

Interview with our CTO and VP Clinical Affairs – How CLS contributes to better treatment of Prostate Cancer

Our CTO Cristina Pantaleone and VP Medical Affairs Hoda Tawfik, explain how the TRANBERG® Thermal Therapy Systems have been designed for precise and safe focal therapy of soft tissue, such as the prostate gland, and what kind of research CLS is now supporting.

Read more
1 November, 2022

CLS Supports Movember - Introduction by CEO Dan J. Mogren

CEO Dan J. Mogren introduces our support for Movember. This annual campaign is all about raising awareness around male health, and specifically around prostate cancer. It is one of the most common cancer forms among men, but more can be done to spread knowledge about the disease.

Read more
17 October, 2022

Demonstration of Targeted Focal Therapy with Fusion-guided Laser Ablation by Dr. Fernando J. Bianco

Combined products enable minimally-invasive, high precision laser focal therapy of prostate tumors in an office or clinic. CLS Americas and Focalyx Technologies, today announced the companies will exhibit and demonstrate their respective products.

Read more
26 September, 2022

CLS receives FDA 510(k) clearance for our MR guided laser ablation system in neurosurgery

We are proud to announce that CLS has received FDA 510(k) clearance for our MR guided laser ablation system in neurosurgery!

Read more
15 September, 2022

Skåne University Hospital prepares to operate patients inside the MRI Scanner

The first patient will shortly be treated with the CLS laser ablation system in a sponsored study at Skåne University Hospital. The Swedish medical journal Läkartidningen now reports from the hospital.

Read more
7 September, 2022

Imperial Prostate Masterclass meeting in London, UK, September 9-10

We are now in the final preparations for the Imperial Prostate Masterclass meeting in London taking place this week. This is a small meeting, but this is also where we well meet the leading specialists and KOLs in the field.

Read more
24 August, 2022

Scientific Meetings and Exhibitions - CLS Participation Autumn 2022

The CLS team is looking forward to showcasing our new product generation towards urologists and radiologists through a variety of activities during the coming autumn...

Read more
9 June, 2022

CLS at Biostock Life Science Spring Summit

CEO Dan J. Mogren is presenting CLS at Biostock Life Science spring summit 2022. Watch the full presentation here.

Read more
19 May, 2022

SVT rapporterar om operationer i magnetkamera på Skånes universitetssjukhus

SVTs lokalnyheter sände i tisdags ett reportage från Skånes universitetssjukhus där patienter opereras inne i en magnetkamera. Så kommer det också gå till när Skånes universitetssjukhus inleder laserablationsbehandlingar av hjärntumörer - med CLS system.

Read more
17 May, 2022

Laserkirurgi i magnetkamera - för bättre precision och patientsäkerhet

CLS och Skånes Universitetssjukhus ser fram mot den kommande kliniska studie där CLS system för laserablation kommer utvärderas för behandling av patienter med tumörsjukdomen glioblastom.

Read more
11 May, 2022

CLS has entered an agreement with Quadia Diagnostic Imaging Center, Poland on a commercial evaluation of our TRANBERG® Thermal Therapy System

CLS has entered an agreement with Quadia Diagnostic Imaging Center in Piaseczno, Poland on a commercial evaluation of its second-generation TRANBERG® Thermal Therapy System with Thermoguide™ Workstation in MR-guided stereotactic focal laser ablation of localized prostate cancer.

Read more
21 April, 2022

CLS Americas and URN Announce First Patient Treated in Clinical Study “Targeted MRI/ US Fusion Transperineal Laser Ablation of Low-to-Intermediate Risk Prostate Cancer”

CLS Americas today announced the first patient has been safely treated in its recently announced 20-patient, Phase I clinical study.

Read more
20 April, 2022

CLS will participate with a booth and hands-on training during ECIO 2022, April 24-27 in Vienna, Austria

CLS is looking forward to participating in the annual European Conference on Interventional Oncology (ECIO) 2022, April 24-27 in Vienna, Austria. The meeting is the world’s most comprehensive platform for education and knowledge exchange within interventional oncology with over 1 450 international delegates attending.

Read more
5 April, 2022

CLS Americas Inc. and URN Announce Clinical Study “Targeted MRI/US Fusion Transperineal Laser Ablation of Low to Intermediate Risk Prostate Cancer”

Clinical Laserthermia Systems AB, today announced the company’s TRANBERG® Thermal Therapy System will be used by Focalyx Technologies, developer of image-guided fusion target devices, to conduct a 20-patient, Phase I clinical study titled, “Targeted MRI/ US Fusion Transperineal Laser Ablation of Low-to-Intermediate Risk Prostate Cancer.”

Read more
18 February, 2022

Radboud University Medical Center (Nijmegen, NL) has initiated a clinical trial using the CLS TRANBERG® products for patients with prostate cancer​

Radboud University Medical Center (Radboudumc) in Nijmegen in the Netherlands has obtained approval from its ethics committee for its Investigator Initiated Trial (IIT) to evaluate the safety and feasibility of magnetic resonance guided focused laser ablation (MRgFLA) as a focal therapy treatment for localized prostate cancer in low to intermediate risk patients, using the TRANBERG® Thermal Therapy System with Thermoguide™ Workstation.

Read more
16 February, 2022

CLS and Skåne University Hospital enter a clinical trial agreement to evaluate laser ablation in glioblastoma patients​

CLS and Skåne University Hospital enter a clinical trial agreement to evaluate laser ablation in glioblastoma patients Clinical Laserthermia Systems AB (publ) (CLS), which develops advanced innovative products for high-precision image guided laser ablation, announces that it has entered into an agreement with Skåne University Hospital to sponsor a clinical trial evaluating the safety and feasibility of […]

Read more

Sign up for our newsletter

Make sure you get all the exciting information about CLS’ progress on an ongoing basis.

Welcome to Clinical Laserthermia Systems.

Please note that all our products and indications are not yet approved in all markets. Don’t hesitate to contact us for up-to-date market approvals in your area!


Please choose your country or region

Global
US